View ValuationCHAPTERS Group 将来の成長Future 基準チェック /56CHAPTERS Group利益と収益がそれぞれ年間86.5%と31.4%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に5.2% 94.1%なると予測されています。主要情報86.5%収益成長率94.06%EPS成長率Diversified Financial 収益成長53.9%収益成長率31.4%将来の株主資本利益率5.19%アナリストカバレッジLow最終更新日07 May 2026今後の成長に関する最新情報Price Target Changed • May 08Price target decreased by 8.2% to €45.00Down from €49.00, the current price target is an average from 2 analysts. New target price is 45% above last closing price of €30.95. Stock is down 13% over the past year. The company is forecast to post a net loss per share of €0.69 next year compared to a net loss per share of €0.50 last year.Major Estimate Revision • Oct 18Consensus EPS estimates fall by 188%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.24 to -€0.69 per share. Revenue forecast of €157.7m unchanged since last update. Diversified Financial industry in Germany expected to see average net income growth of 75% next year. Consensus price target of €48.00 unchanged from last update. Share price was steady at €38.00 over the past week.Major Estimate Revision • Sep 11Consensus EPS estimates fall by 118%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €166.0m to €157.7m. Losses expected to increase from €0.11 per share to €0.24. Diversified Financial industry in Germany expected to see average net income growth of 50% next year. Consensus price target down from €49.00 to €48.00. Share price fell 7.8% to €34.30 over the past week.Major Estimate Revision • Aug 19Consensus revenue estimates increase by 12%, EPS downgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from €148.1m to €166.0m. EPS expected loss of €0.11 per share, down from profit of €1.12 per share previously. Diversified Financial industry in Germany expected to see average net income growth of 86% next year. Consensus price target of €49.00 unchanged from last update. Share price was steady at €41.10 over the past week.Price Target Changed • May 23Price target increased by 44% to €49.00Up from €34.00, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €40.60. Stock is up 71% over the past year. The company is forecast to post earnings per share of €0.37 next year compared to a net loss per share of €0.23 last year.Price Target Changed • Feb 12Price target increased by 26% to €34.00Up from €27.00, the current price target is provided by 1 analyst. New target price is 8.3% above last closing price of €31.40. Stock is up 75% over the past year. The company is forecast to post earnings per share of €0.36 next year compared to a net loss per share of €0.23 last year.すべての更新を表示Recent updatesPrice Target Changed • May 08Price target decreased by 8.2% to €45.00Down from €49.00, the current price target is an average from 2 analysts. New target price is 45% above last closing price of €30.95. Stock is down 13% over the past year. The company is forecast to post a net loss per share of €0.69 next year compared to a net loss per share of €0.50 last year.New Risk • Apr 30New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (8.6% average weekly change).New Risk • Apr 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.分析記事 • Feb 10CHAPTERS Group AG's (ETR:CHG) Popularity With Investors Under Threat As Stock Sinks 27%CHAPTERS Group AG ( ETR:CHG ) shares have had a horrible month, losing 27% after a relatively good period beforehand...分析記事 • Dec 22CHAPTERS Group AG's (ETR:CHG) Share Price Not Quite Adding UpWhen you see that almost half of the companies in the Diversified Financial industry in Germany have price-to-sales...Major Estimate Revision • Oct 18Consensus EPS estimates fall by 188%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.24 to -€0.69 per share. Revenue forecast of €157.7m unchanged since last update. Diversified Financial industry in Germany expected to see average net income growth of 75% next year. Consensus price target of €48.00 unchanged from last update. Share price was steady at €38.00 over the past week.Reported Earnings • Oct 15First half 2025 earnings released: €0.69 loss per share (vs €0.23 loss in 1H 2024)First half 2025 results: €0.69 loss per share (further deteriorated from €0.23 loss in 1H 2024). Revenue: €71.0m (up 42% from 1H 2024). Net loss: €16.1m (loss widened 259% from 1H 2024). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 46% per year, which means it is well ahead of earnings.Major Estimate Revision • Sep 11Consensus EPS estimates fall by 118%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €166.0m to €157.7m. Losses expected to increase from €0.11 per share to €0.24. Diversified Financial industry in Germany expected to see average net income growth of 50% next year. Consensus price target down from €49.00 to €48.00. Share price fell 7.8% to €34.30 over the past week.Major Estimate Revision • Aug 19Consensus revenue estimates increase by 12%, EPS downgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from €148.1m to €166.0m. EPS expected loss of €0.11 per share, down from profit of €1.12 per share previously. Diversified Financial industry in Germany expected to see average net income growth of 86% next year. Consensus price target of €49.00 unchanged from last update. Share price was steady at €41.10 over the past week.New Risk • Jul 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Shareholders have been diluted in the past year (29% increase in shares outstanding).お知らせ • Jun 02CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025, at 14:00 W. Europe Standard Time.分析記事 • Jun 02CHAPTERS Group AG's (ETR:CHG) Shares Climb 36% But Its Business Is Yet to Catch UpDespite an already strong run, CHAPTERS Group AG ( ETR:CHG ) shares have been powering on, with a gain of 36% in the...Reported Earnings • Jun 02Full year 2024 earnings: Revenues in line with analyst expectationsFull year 2024 results: Revenue: €119.1m (up 68% from FY 2023). Net loss: €11.5m (loss widened 181% from FY 2023). Revenue was in line with analyst estimates. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany.Price Target Changed • May 23Price target increased by 44% to €49.00Up from €34.00, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €40.60. Stock is up 71% over the past year. The company is forecast to post earnings per share of €0.37 next year compared to a net loss per share of €0.23 last year.お知らせ • May 23Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG).Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG) on May 22, 2025. Bastian Krieghoff, CEO of Fintiba, will be appointed to the Executive Board of CHAPTERS Group AG by the Supervisory Board. The transaction is subject to the usual contractual conditions is expected to close in May 2025.New Risk • May 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (39% increase in shares outstanding). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).Price Target Changed • Feb 12Price target increased by 26% to €34.00Up from €27.00, the current price target is provided by 1 analyst. New target price is 8.3% above last closing price of €31.40. Stock is up 75% over the past year. The company is forecast to post earnings per share of €0.36 next year compared to a net loss per share of €0.23 last year.New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 39% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company.分析記事 • Jan 10Why We're Not Concerned About CHAPTERS Group AG's (ETR:CHG) Share PriceWhen close to half the companies in the Diversified Financial industry in Germany have price-to-sales ratios (or "P/S...Reported Earnings • Oct 23First half 2024 earnings released: €0.23 loss per share (vs €0.18 loss in 1H 2023)First half 2024 results: €0.23 loss per share (further deteriorated from €0.18 loss in 1H 2023). Revenue: €50.0m (up 49% from 1H 2023). Net loss: €4.48m (loss widened 49% from 1H 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 39% per year, which means it is well ahead of earnings.お知らせ • Oct 18CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG.CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG on October 18, 2024. Xplain includes the two companies Xplain AG and the Spanish development partner Xplain Ibérica. Both will continue to operate independently, as Andreas Löwinger, CEO of Xplain AG, told the Keystone-SDA news agency. The total of 60 employees of both companies will keep their jobs. All projects will also be continued. Löwinger will remain CEO until a successor is found. CHAPTERS Group AG (XTRA:CHG) completed the acquisition of Xplain AG on October 18, 2024.New Risk • Jun 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).お知らせ • Jun 05CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024, at 14:00 W. Europe Standard Time.Reported Earnings • May 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €78.3m (up 86% from FY 2022). Net loss: €4.08m (loss narrowed 38% from FY 2022). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).Price Target Changed • Mar 15Price target increased by 14% to €24.00Up from €21.00, the current price target is provided by 1 analyst. New target price is 18% above last closing price of €20.40. Stock is up 67% over the past year. The company is forecast to post earnings per share of €0.09 next year compared to a net loss per share of €0.41 last year.分析記事 • Mar 09CHAPTERS Group AG's (ETR:CHG) Popularity With Investors Is ClearCHAPTERS Group AG's ( ETR:CHG ) price-to-sales (or "P/S") ratio of 6x may look like a poor investment opportunity when...お知らせ • Mar 07CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024.分析記事 • Nov 18CHAPTERS Group AG (ETR:CHG) Stocks Shoot Up 29% But Its P/S Still Looks ReasonableCHAPTERS Group AG ( ETR:CHG ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...分析記事 • Nov 09We Think CHAPTERS Group (ETR:CHG) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • Oct 05First half 2023 earnings released: €0.25 loss per share (vs €0.035 profit in 1H 2022)First half 2023 results: €0.25 loss per share (down from €0.035 profit in 1H 2022). Revenue: €33.7m (up 77% from 1H 2022). Net loss: €4.20m (down €4.72m from profit in 1H 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 44% per year.New Risk • Oct 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).New Risk • Sep 04New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company.お知らせ • Dec 14MEDIQON Group AG announced that it has received fundingMEDIQON Group AG announced that a private placement of successfully completion of the capital increase on December 12, 2022.分析記事 • Oct 08These 4 Measures Indicate That MEDIQON Group (ETR:MCE) Is Using Debt Reasonably WellSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • May 30Full year 2021 earnings released: €0.21 loss per share (vs €0.68 loss in FY 2020)Full year 2021 results: €0.21 loss per share (up from €0.68 loss in FY 2020). Revenue: €28.7m (up €27.6m from FY 2020). Net loss: €2.27m (flat on FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 112 percentage points per year, which is a significant difference in performance.分析記事 • Oct 27Here's Why MEDIQON Group (ETR:MCE) Can Afford Some DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Sep 22First half 2021 earnings releasedFirst half 2021 results: Net income: €15.7k (up €29.8k from 1H 2020).Reported Earnings • Jun 29Full year 2020 earnings releasedFull year 2020 results: Net loss: €2.27m (loss narrowed 55% from FY 2019).Is New 90 Day High Low • Feb 12New 90-day high: €5.40The company is up 11% from its price of €4.88 on 13 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 5.0% over the same period.Is New 90 Day High Low • Jan 27New 90-day low: €4.24The company is down 9.0% from its price of €4.64 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 11% over the same period.Is New 90 Day High Low • Oct 01New 90-day low: €4.74The company is down 18% from its price of €5.80 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 9.0% over the same period.業績と収益の成長予測XTRA:CHG - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20284886N/AN/A112/31/202730856283212/31/2026219-44662212/31/2025158-16102916/30/2025132-231418N/A3/31/2025121-171015N/A12/31/2024111-11711N/A9/30/202499-9711N/A6/30/202487-6711N/A3/31/202479-559N/A12/31/202371-447N/A9/30/202364-758N/A6/30/202357-958N/A3/31/202349-847N/A12/31/202242-646N/A9/30/202245-456N/A6/30/202248-257N/A3/31/202238-245N/A12/31/202129-223N/A9/30/202114-2N/AN/AN/A6/30/20210-2N/AN/AN/A3/31/20211-2N/AN/AN/A12/31/20201-2N/AN/AN/A9/30/20201-4N/AN/AN/A6/30/20201-5N/AN/AN/A3/31/20201-5N/AN/AN/A12/31/20190-5N/AN/AN/A9/30/201911N/AN/AN/A6/30/201918N/AN/AN/A3/31/201928N/AN/AN/A12/31/201838N/AN/AN/A9/30/201834N/AN/AN/A6/30/201830N/AN/AN/A3/31/201830N/AN/AN/A12/31/201731N/AN/AN/A9/30/201730N/AN/AN/A6/30/201730N/AN/AN/A3/31/201730N/AN/AN/A12/31/201630N/AN/AN/A9/30/201630N/AN/AN/A6/30/201630N/AN/AN/A3/31/201630N/AN/AN/A12/31/201530N/AN/AN/A9/30/201530N/AN/AN/A6/30/201531N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: CHGは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 1.9% ) よりも高い成長率であると考えられます。収益対市場: CHG今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。高成長収益: CHG今後 3 年以内に収益を上げることが予想されます。収益対市場: CHGの収益 ( 31.4% ) German市場 ( 6.8% ) よりも速いペースで成長すると予測されています。高い収益成長: CHGの収益 ( 31.4% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: CHGの 自己資本利益率 は、3年後には低くなると予測されています ( 5.2 %)。成長企業の発掘7D1Y7D1Y7D1YDiversified-financials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 22:20終値2026/05/22 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋CHAPTERS Group AG 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Andreas WolfBerenbergAlexander Zienkowiczmwb research AG
Price Target Changed • May 08Price target decreased by 8.2% to €45.00Down from €49.00, the current price target is an average from 2 analysts. New target price is 45% above last closing price of €30.95. Stock is down 13% over the past year. The company is forecast to post a net loss per share of €0.69 next year compared to a net loss per share of €0.50 last year.
Major Estimate Revision • Oct 18Consensus EPS estimates fall by 188%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.24 to -€0.69 per share. Revenue forecast of €157.7m unchanged since last update. Diversified Financial industry in Germany expected to see average net income growth of 75% next year. Consensus price target of €48.00 unchanged from last update. Share price was steady at €38.00 over the past week.
Major Estimate Revision • Sep 11Consensus EPS estimates fall by 118%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €166.0m to €157.7m. Losses expected to increase from €0.11 per share to €0.24. Diversified Financial industry in Germany expected to see average net income growth of 50% next year. Consensus price target down from €49.00 to €48.00. Share price fell 7.8% to €34.30 over the past week.
Major Estimate Revision • Aug 19Consensus revenue estimates increase by 12%, EPS downgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from €148.1m to €166.0m. EPS expected loss of €0.11 per share, down from profit of €1.12 per share previously. Diversified Financial industry in Germany expected to see average net income growth of 86% next year. Consensus price target of €49.00 unchanged from last update. Share price was steady at €41.10 over the past week.
Price Target Changed • May 23Price target increased by 44% to €49.00Up from €34.00, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €40.60. Stock is up 71% over the past year. The company is forecast to post earnings per share of €0.37 next year compared to a net loss per share of €0.23 last year.
Price Target Changed • Feb 12Price target increased by 26% to €34.00Up from €27.00, the current price target is provided by 1 analyst. New target price is 8.3% above last closing price of €31.40. Stock is up 75% over the past year. The company is forecast to post earnings per share of €0.36 next year compared to a net loss per share of €0.23 last year.
Price Target Changed • May 08Price target decreased by 8.2% to €45.00Down from €49.00, the current price target is an average from 2 analysts. New target price is 45% above last closing price of €30.95. Stock is down 13% over the past year. The company is forecast to post a net loss per share of €0.69 next year compared to a net loss per share of €0.50 last year.
New Risk • Apr 30New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (8.6% average weekly change).
New Risk • Apr 04New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
分析記事 • Feb 10CHAPTERS Group AG's (ETR:CHG) Popularity With Investors Under Threat As Stock Sinks 27%CHAPTERS Group AG ( ETR:CHG ) shares have had a horrible month, losing 27% after a relatively good period beforehand...
分析記事 • Dec 22CHAPTERS Group AG's (ETR:CHG) Share Price Not Quite Adding UpWhen you see that almost half of the companies in the Diversified Financial industry in Germany have price-to-sales...
Major Estimate Revision • Oct 18Consensus EPS estimates fall by 188%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -€0.24 to -€0.69 per share. Revenue forecast of €157.7m unchanged since last update. Diversified Financial industry in Germany expected to see average net income growth of 75% next year. Consensus price target of €48.00 unchanged from last update. Share price was steady at €38.00 over the past week.
Reported Earnings • Oct 15First half 2025 earnings released: €0.69 loss per share (vs €0.23 loss in 1H 2024)First half 2025 results: €0.69 loss per share (further deteriorated from €0.23 loss in 1H 2024). Revenue: €71.0m (up 42% from 1H 2024). Net loss: €16.1m (loss widened 259% from 1H 2024). Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 46% per year, which means it is well ahead of earnings.
Major Estimate Revision • Sep 11Consensus EPS estimates fall by 118%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from €166.0m to €157.7m. Losses expected to increase from €0.11 per share to €0.24. Diversified Financial industry in Germany expected to see average net income growth of 50% next year. Consensus price target down from €49.00 to €48.00. Share price fell 7.8% to €34.30 over the past week.
Major Estimate Revision • Aug 19Consensus revenue estimates increase by 12%, EPS downgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from €148.1m to €166.0m. EPS expected loss of €0.11 per share, down from profit of €1.12 per share previously. Diversified Financial industry in Germany expected to see average net income growth of 86% next year. Consensus price target of €49.00 unchanged from last update. Share price was steady at €41.10 over the past week.
New Risk • Jul 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Shareholders have been diluted in the past year (29% increase in shares outstanding).
お知らせ • Jun 02CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025, at 14:00 W. Europe Standard Time.
分析記事 • Jun 02CHAPTERS Group AG's (ETR:CHG) Shares Climb 36% But Its Business Is Yet to Catch UpDespite an already strong run, CHAPTERS Group AG ( ETR:CHG ) shares have been powering on, with a gain of 36% in the...
Reported Earnings • Jun 02Full year 2024 earnings: Revenues in line with analyst expectationsFull year 2024 results: Revenue: €119.1m (up 68% from FY 2023). Net loss: €11.5m (loss widened 181% from FY 2023). Revenue was in line with analyst estimates. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany.
Price Target Changed • May 23Price target increased by 44% to €49.00Up from €34.00, the current price target is provided by 1 analyst. New target price is 21% above last closing price of €40.60. Stock is up 71% over the past year. The company is forecast to post earnings per share of €0.37 next year compared to a net loss per share of €0.23 last year.
お知らせ • May 23Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG).Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG) on May 22, 2025. Bastian Krieghoff, CEO of Fintiba, will be appointed to the Executive Board of CHAPTERS Group AG by the Supervisory Board. The transaction is subject to the usual contractual conditions is expected to close in May 2025.
New Risk • May 06New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shareholders have been substantially diluted in the past year (39% increase in shares outstanding). Minor Risk Latest financial reports are more than 6 months old (reported June 2024 fiscal period end).
Price Target Changed • Feb 12Price target increased by 26% to €34.00Up from €27.00, the current price target is provided by 1 analyst. New target price is 8.3% above last closing price of €31.40. Stock is up 75% over the past year. The company is forecast to post earnings per share of €0.36 next year compared to a net loss per share of €0.23 last year.
New Risk • Jan 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 39% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company.
分析記事 • Jan 10Why We're Not Concerned About CHAPTERS Group AG's (ETR:CHG) Share PriceWhen close to half the companies in the Diversified Financial industry in Germany have price-to-sales ratios (or "P/S...
Reported Earnings • Oct 23First half 2024 earnings released: €0.23 loss per share (vs €0.18 loss in 1H 2023)First half 2024 results: €0.23 loss per share (further deteriorated from €0.18 loss in 1H 2023). Revenue: €50.0m (up 49% from 1H 2023). Net loss: €4.48m (loss widened 49% from 1H 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 39% per year, which means it is well ahead of earnings.
お知らせ • Oct 18CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG.CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG on October 18, 2024. Xplain includes the two companies Xplain AG and the Spanish development partner Xplain Ibérica. Both will continue to operate independently, as Andreas Löwinger, CEO of Xplain AG, told the Keystone-SDA news agency. The total of 60 employees of both companies will keep their jobs. All projects will also be continued. Löwinger will remain CEO until a successor is found. CHAPTERS Group AG (XTRA:CHG) completed the acquisition of Xplain AG on October 18, 2024.
New Risk • Jun 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).
お知らせ • Jun 05CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024, at 14:00 W. Europe Standard Time.
Reported Earnings • May 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €78.3m (up 86% from FY 2022). Net loss: €4.08m (loss narrowed 38% from FY 2022). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).
Price Target Changed • Mar 15Price target increased by 14% to €24.00Up from €21.00, the current price target is provided by 1 analyst. New target price is 18% above last closing price of €20.40. Stock is up 67% over the past year. The company is forecast to post earnings per share of €0.09 next year compared to a net loss per share of €0.41 last year.
分析記事 • Mar 09CHAPTERS Group AG's (ETR:CHG) Popularity With Investors Is ClearCHAPTERS Group AG's ( ETR:CHG ) price-to-sales (or "P/S") ratio of 6x may look like a poor investment opportunity when...
お知らせ • Mar 07CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024.
分析記事 • Nov 18CHAPTERS Group AG (ETR:CHG) Stocks Shoot Up 29% But Its P/S Still Looks ReasonableCHAPTERS Group AG ( ETR:CHG ) shares have had a really impressive month, gaining 29% after a shaky period beforehand...
分析記事 • Nov 09We Think CHAPTERS Group (ETR:CHG) Can Stay On Top Of Its DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • Oct 05First half 2023 earnings released: €0.25 loss per share (vs €0.035 profit in 1H 2022)First half 2023 results: €0.25 loss per share (down from €0.035 profit in 1H 2022). Revenue: €33.7m (up 77% from 1H 2022). Net loss: €4.20m (down €4.72m from profit in 1H 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 44% per year.
New Risk • Oct 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.1% average weekly change). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).
New Risk • Sep 04New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company.
お知らせ • Dec 14MEDIQON Group AG announced that it has received fundingMEDIQON Group AG announced that a private placement of successfully completion of the capital increase on December 12, 2022.
分析記事 • Oct 08These 4 Measures Indicate That MEDIQON Group (ETR:MCE) Is Using Debt Reasonably WellSome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • May 30Full year 2021 earnings released: €0.21 loss per share (vs €0.68 loss in FY 2020)Full year 2021 results: €0.21 loss per share (up from €0.68 loss in FY 2020). Revenue: €28.7m (up €27.6m from FY 2020). Net loss: €2.27m (flat on FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 112 percentage points per year, which is a significant difference in performance.
分析記事 • Oct 27Here's Why MEDIQON Group (ETR:MCE) Can Afford Some DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Sep 22First half 2021 earnings releasedFirst half 2021 results: Net income: €15.7k (up €29.8k from 1H 2020).
Reported Earnings • Jun 29Full year 2020 earnings releasedFull year 2020 results: Net loss: €2.27m (loss narrowed 55% from FY 2019).
Is New 90 Day High Low • Feb 12New 90-day high: €5.40The company is up 11% from its price of €4.88 on 13 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Jan 27New 90-day low: €4.24The company is down 9.0% from its price of €4.64 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 11% over the same period.
Is New 90 Day High Low • Oct 01New 90-day low: €4.74The company is down 18% from its price of €5.80 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 9.0% over the same period.